2016年5月， 中南大学湘雅二医院 在OncoTargets and Therapy（IF2.7001/4区）期刊上发表了一篇论文。在 发表9年后 ，因 图片组内重复 在pubpeer上被读者质疑。

Figure 1: Classification of captured proteins from HepG2 cell lysate using cAMP Capture Compounds, based on their biological process properties. Guanosine nucleotide binding proteins (G proteins ...

To elucidate the mechanism further, HepG2 cells were treated with an adenosine monophosphate-activated protein kinase (AMPK) inhibitor to test whether SOX9 acts via AMPK activation. SOX9 ...

Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.